Eisai Inc., the U.S. pharmaceutical subsidiary of Eisai Co., Ltd., announced today the presentation of two posters highlighting the latest data on elenbecestat (development code: E2609), its...

Kadaxis announced that it has been named BookTech Company of the Year at the 2016 FutureBook Awards. The FutureBook conference, run by The Bookseller, is Europe's largest digital publishing...

Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai Inc. today announced new interim data investigating Merck's anti-PD-1 therapy, KEYTRUDA® (pembrolizumab), in...

By 2018, sales of service robots for personal and domestic use will reach 35M units according to the International Robotics Federation. Get a first look at the robots responsible for changing the...

Forge Therapeutics, Inc. announced today that new preclinical data on its novel class of antibiotic targeting LpxC for treating infections by Gram-negative drug resistant bacteria will be...